HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 70 filers reported holding HARPOON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $630,000 | -65.9% | 329,842 | -11.4% | 0.01% | -58.3% |
| Q1 2022 | $1,849,000 | -25.1% | 372,097 | +13.9% | 0.01% | -29.4% |
| Q4 2021 | $2,467,000 | +258.6% | 326,808 | +275.2% | 0.02% | +240.0% |
| Q3 2021 | $688,000 | -35.6% | 87,103 | +35.3% | 0.01% | -44.4% |
| Q4 2020 | $1,069,000 | -7.8% | 64,388 | -5.6% | 0.01% | -25.0% |
| Q3 2020 | $1,159,000 | +23.8% | 68,225 | +21.0% | 0.01% | +20.0% |
| Q2 2020 | $936,000 | +175.3% | 56,371 | +92.0% | 0.01% | +150.0% |
| Q1 2020 | $340,000 | – | 29,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $2,335,957 | 1.93% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $2,329,753 | 0.97% |
| MPM BioImpact LLC | 3,196,707 | $2,378,350 | 0.62% |
| Lion Point Capital, LP | 169,283 | $125,980 | 0.05% |
| Artal Group S.A. | 1,000,000 | $744 | 0.04% |
| Cormorant Asset Management, LP | 540,600 | $402 | 0.03% |
| KENNEDY CAPITAL MANAGEMENT LLC | 529,934 | $394,377 | 0.01% |
| Orbimed Advisors | 621,218 | $462,310 | 0.01% |
| Tekla Capital Management LLC | 259,910 | $193,425 | 0.01% |
| CM WEALTH ADVISORS LLC | 50,354 | $29 | 0.01% |